VANGUARD GROUP INC - 30 Sep 2025 SCHEDULE 13G/A Report for Vistagen Therapeutics Inc Common Stock (VTGN)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Vistagen Therapeutics Inc Common Stock
Symbol: VTGN
Shares outstanding: 30.7M shares
Disclosed Ownership: 1.69M shares
Ownership: 5.5%
Form type: SCHEDULE 13G/A
Filing time: 31 Oct 2025, 11:41:57 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5.5%	1.69M	0	180K	Ashley Grim	Head of Global Fund Administration